Efficacy Results Of Selective Axl Inhibitor Bemcentinib With Pembrolizumab Following Chemo In Patients With Nsclc
J. M. Trigo Perez, E. Felip,P. Brunsvig,A. Helland,N. Vinolas,S. Ponce Aix,E. Carcereny Costa,M. Domine Gomez,E. Arriola,R. Garcia Campelo, J. Spicer,J. R. Thompson,A. L. Ortega Granados,R. J. Holt,J. B. Lorens, M. Shoaib, A. Siddiqui,E. V. Schmidt, M. J. Chisamore, M. G. Krebs Annals of Oncology（2019）
关键词
bemcentinib, AXL, Pembrolizumab
AI 理解论文
溯源树
样例
